Developer docs
API playgroundTry for free, no card

Search company profiles

Ellex

Full company profile

uuid0009rpw

Namestring
Ellex
Legal namestring
Ellex
Websiteurl
ellex.com
Company typeenum
Private
Founded yearint
1985
Descriptiontext

Ellex is an Australian-founded ophthalmic medical device firm, established in 1985, that develops and markets precision laser systems for the diagnosis and treatment of eye conditions. Its product portfolio centers on three laser modalities: YAG lasers for posterior capsule opacification and anterior/posterior segment procedures, selective laser trabeculoplasty (SLT) lasers for glaucoma management, and retinal photocoagulator lasers. Flagship systems include the Tango Reflex Neo (YAG/SLT combination featuring proprietary True Coaxial Illumination), the Ultra Q Reflex Neo (YAG laser), the Tango Neo (SLT/YAG combination), the Solo (standalone SLT laser), and the Easyret 577nm fiber-based retinal platform with SingleSpot, MultiSpot, and Subliminal treatment modes. Ellex also markets the Integre Pro and Vitra 2 multi-spot photocoagulators and the Optimis Fusion and Capsulo modular platforms that combine with Vitra 2.

Ellex operates as a brand within Lumibird Medical, the medical division of France-based Lumibird Group, which also houses Quantel Medical and Optotek Medical. The company's offerings target four primary buyer personas - anterior segment specialists, retina specialists, glaucoma specialists, and cataract surgeons - through a hybrid commercial model: direct sales via Lumibird Medical subsidiaries in major markets and a distributor network that, in aggregate with parent-level reach, covers 110 countries. Active markets explicitly identified in the source material span North America (USA), Europe (France, Germany, UK, Italy, Spain, Finland, Norway, Poland, Sweden), and Asia Pacific (Australia, Japan).

The business model is capital-equipment sales to specialist ophthalmic practices and clinics, supplemented by consumables, service, and training; pricing is not publicly disclosed. Post-sale engagement is supported through the Ellex Community Portal, clinical case studies, a media library, and newsletters, with mid-funnel content marketing aimed at clinician education. As a privately held division within Lumibird Group, Ellex does not publish standalone revenue figures, and operating decisions are integrated with the parent medical division rather than independently reported.

Short descriptiontext

Ellex is an Australian-founded ophthalmic medical device brand, now operating under Lumibird Medical, that designs and sells YAG, SLT, and retinal laser systems for anterior segment, glaucoma, retina, and cataract specialists across 110 countries via subsidiaries and distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCoalstoun Lakes, Australia
HQ citystring
Coalstoun Lakes
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Keyword5 values
ophthalmic laser systems, YAG laser devices, SLT laser therapy, retinal photocoagulators, glaucoma laser treatment
Industry1 code
1Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics)
CodeHLAHAJAHPrimaryYes
NAICS code2 codes
  • Ophthalmic Goods Manufacturing339115
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Ophthalmic Medical Devices
Social media profiles1 record
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1Tango Reflex Neo
Description

Premium YAG/SLT Laser featuring True Coaxial Illumination technology for SLT and YAG indications

ophthalmology.lumibirdmedical.com
+9 more records
Core offering1 text field

Ellex designs, manufactures, and sells ophthalmic laser systems used by eye-care professionals to treat anterior segment and retinal conditions. Its portfolio includes YAG lasers (for capsulotomy and iridotomy), Selective Laser Trabeculoplasty (SLT) lasers for glaucoma, and 577nm/532nm retinal photocoagulators with SingleSpot, MultiSpot, and Subliminal treatment modes. Products are sold globally as part of the Lumibird Medical portfolio under the Ellex brand.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Ellex is a brand under Lumibird Medical specializing in ophthalmic laser technologies for anterior segment treatments. The product portfolio consists of four core laser products: Tango Reflex Neo (YAG/SLT with True Coaxial Illumination), Ultra Q Reflex Neo (YAG laser), Tango Neo (SLT/YAG combination), and Solo (standalone SLT laser). These products serve anterior chamber specialists and glaucoma treatment applications, offering precision and efficiency in patient care through various laser modalities including selective laser trabeculoplasty (SLT) and YAG laser procedures.

Product and service5 records
1Tango Reflex Neo
CategoryOphthalmic Laser Systems
Description

Premium combined YAG and SLT laser system featuring True Coaxial Illumination technology, intended for ophthalmologists performing SLT (Selective Laser Trabeculoplasty) and YAG laser procedures such as capsulotomy and iridotomy.

2Ultra Q Reflex Neo
CategoryOphthalmic Laser Systems
Description

Premium YAG laser platform that enables ophthalmologists to perform the full range of anterior and posterior YAG laser procedures, including capsulotomy, iridotomy, and vitreolysis.

3Tango Neo
CategoryOphthalmic Laser Systems
Description

Combined SLT and YAG laser system that allows ophthalmologists to perform both SLT and YAG treatments on a single platform with improved accuracy and greater long-term efficacy.

4Solo
CategoryOphthalmic Laser Systems
Description

Standalone Selective Laser Trabeculoplasty (SLT) laser positioned as the industry's most advanced SLT laser, used by ophthalmologists for glaucoma management.

5Integre Pro (and Integre Pro Scan)
CategoryOphthalmic Laser Systems
Description

Integrated multicolor photocoagulator laser system offering SingleSpot and MultiSpot delivery modes for retinal and other ophthalmic laser treatments.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Lumenis is a direct competitor in ophthalmic lasers with YAG, SLT, and retina laser systems sold into similar ophthalmologist and hospital channels. Its product portfolio directly overlaps Ellex's Tango, Ultra Q, and Solo families.

TypeDirect peer
Description

Iridex manufactures ophthalmic laser systems for glaucoma and retinal treatments, directly overlapping Ellex's SLT and retinal photocoagulation product lines. Both companies target retina and glaucoma specialists with comparable capital equipment.

TypeDirect peer
Description

Quantel Medical is a sister brand under Lumibird Medical, marketing adjacent ophthalmic laser and ultrasound products. It shares customer base, distribution, and parent-company support with Ellex, and competes for overlapping ophthalmic device budgets.

TypeBroad incumbent
Description

Nidek is a broad ophthalmic device incumbent offering YAG/SLT lasers, photocoagulators, and diagnostic platforms globally. It competes with Ellex across multiple laser modalities and benefits from a much larger portfolio and broader geographic footprint.

TypeBroad incumbent
Description

Zeiss Meditec is a dominant ophthalmic surgical and diagnostic incumbent whose laser offerings (YAG, retina) directly overlap Ellex's product range. Its bundled capital equipment solutions and global scale make it a powerful competitor in shared accounts.

TypeBroad incumbent
Description

Alcon is one of the largest global ophthalmic device companies, with laser, IOL, and phaco systems that compete with Ellex's offerings in cataract and glaucoma procedure rooms. Its scale and bundled procurement programs create competitive pressure on standalone laser specialists.

TypeBroad incumbent
Description

Bausch + Lomb operates across ophthalmic pharmaceuticals, IOLs, and surgical devices including laser platforms. It competes with Ellex for ophthalmologist capital expenditure and offers bundled cataract surgery suites that include laser technology.

TypeBroad incumbent
Description

Topcon Healthcare offers a broad ophthalmic portfolio spanning diagnostic imaging, refractive, and surgical laser systems. It serves the same ophthalmologist customer base as Ellex and competes in capital equipment purchasing decisions.

TypeEmerging player
Description

LightMed is a smaller ophthalmic laser specialist with YAG and SLT platforms that directly compete with Ellex's Tango and Solo lines. It represents an emerging alternative for cost-conscious ophthalmology practices.

TypeDirect peer
Description

Optotek Medical is a sister brand under Lumibird Medical with overlapping ophthalmic laser and diagnostic offerings. It shares the same parent company, sales channels, and clinical customer base as Ellex, making it the closest internal peer.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ellex

Ophthalmic Medical Devicesellex.com

Ellex is an Australian-founded ophthalmic medical device brand, now operating under Lumibird Medical, that designs and sells YAG, SLT, and retinal laser systems for anterior segment, glaucoma, retina, and cataract specialists across 110 countries via subsidiaries and distributors.

What Ellex does

Ellex is an Australian-founded ophthalmic medical device firm, established in 1985, that develops and markets precision laser systems for the diagnosis and treatment of eye conditions. Its product portfolio centers on three laser modalities: YAG lasers for posterior capsule opacification and anterior/posterior segment procedures, selective laser trabeculoplasty (SLT) lasers for glaucoma management, and retinal photocoagulator lasers. Flagship systems include the Tango Reflex Neo (YAG/SLT combination featuring proprietary True Coaxial Illumination), the Ultra Q Reflex Neo (YAG laser), the Tango Neo (SLT/YAG combination), the Solo (standalone SLT laser), and the Easyret 577nm fiber-based retinal platform with SingleSpot, MultiSpot, and Subliminal treatment modes. Ellex also markets the Integre Pro and Vitra 2 multi-spot photocoagulators and the Optimis Fusion and Capsulo modular platforms that combine with Vitra 2.

Ellex operates as a brand within Lumibird Medical, the medical division of France-based Lumibird Group, which also houses Quantel Medical and Optotek Medical. The company's offerings target four primary buyer personas - anterior segment specialists, retina specialists, glaucoma specialists, and cataract surgeons - through a hybrid commercial model: direct sales via Lumibird Medical subsidiaries in major markets and a distributor network that, in aggregate with parent-level reach, covers 110 countries. Active markets explicitly identified in the source material span North America (USA), Europe (France, Germany, UK, Italy, Spain, Finland, Norway, Poland, Sweden), and Asia Pacific (Australia, Japan).

The business model is capital-equipment sales to specialist ophthalmic practices and clinics, supplemented by consumables, service, and training; pricing is not publicly disclosed. Post-sale engagement is supported through the Ellex Community Portal, clinical case studies, a media library, and newsletters, with mid-funnel content marketing aimed at clinician education. As a privately held division within Lumibird Group, Ellex does not publish standalone revenue figures, and operating decisions are integrated with the parent medical division rather than independently reported.

Ellex firmographics

Firmographics
Name
Ellex
Legal name
Ellex
Website
https://ellex.com
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
101–250 employees
Short description
Ellex is an Australian-founded ophthalmic medical device brand, now operating under Lumibird Medical, that designs and sells YAG, SLT, and retinal laser systems for anterior segment, glaucoma, retina, and cataract specialists across 110 countries via subsidiaries and distributors.
Ownership category
akta.pro rank

Ellex industry classification

Industry
Product category
Ophthalmic Medical Devices
NAICS
Ophthalmic Goods Manufacturing (339115), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

Keywords

  • Ophthalmic laser systems
  • YAG laser devices
  • SLT laser therapy
  • Retinal photocoagulators
  • Glaucoma laser treatment

Where Ellex is headquartered

Location

Headquarters

HQ city
Coalstoun Lakes
HQ country
Australia
HQ region
Oceania

Markets served

Ellex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Distribution channels3 records

Marketing channels4 records

Ellex product offering

Product offering

Core offering

Ellex designs, manufactures, and sells ophthalmic laser systems used by eye-care professionals to treat anterior segment and retinal conditions. Its portfolio includes YAG lasers (for capsulotomy and iridotomy), Selective Laser Trabeculoplasty (SLT) lasers for glaucoma, and 577nm/532nm retinal photocoagulators with SingleSpot, MultiSpot, and Subliminal treatment modes. Products are sold globally as part of the Lumibird Medical portfolio under the Ellex brand.

Product overview

Ellex is a brand under Lumibird Medical specializing in ophthalmic laser technologies for anterior segment treatments. The product portfolio consists of four core laser products: Tango Reflex Neo (YAG/SLT with True Coaxial Illumination), Ultra Q Reflex Neo (YAG laser), Tango Neo (SLT/YAG combination), and Solo (standalone SLT laser). These products serve anterior chamber specialists and glaucoma treatment applications, offering precision and efficiency in patient care through various laser modalities including selective laser trabeculoplasty (SLT) and YAG laser procedures.

Differentiator

Problem solved

Functional benefit

Brands

  • Tango Reflex Neo: Premium YAG/SLT Laser featuring True Coaxial Illumination technology for SLT and YAG indications
  • Ultra Q Reflex Neo
  • Tango Neo
  • Solo
  • Optimis Fusion
  • Capsulo
  • Easyret
  • Integre Pro
  • Vitra 2
  • Ellex Community Portal

Products and services

  • Tango Reflex Neo Premium combined YAG and SLT laser system featuring True Coaxial Illumination technology, intended for ophthalmologists performing SLT (Selective Laser Trabeculoplasty) and YAG laser procedures such as capsulotomy and iridotomy.
  • Ultra Q Reflex Neo Premium YAG laser platform that enables ophthalmologists to perform the full range of anterior and posterior YAG laser procedures, including capsulotomy, iridotomy, and vitreolysis.
  • Tango Neo Combined SLT and YAG laser system that allows ophthalmologists to perform both SLT and YAG treatments on a single platform with improved accuracy and greater long-term efficacy.
  • Solo Standalone Selective Laser Trabeculoplasty (SLT) laser positioned as the industry's most advanced SLT laser, used by ophthalmologists for glaucoma management.
  • Integre Pro (and Integre Pro Scan) Integrated multicolor photocoagulator laser system offering SingleSpot and MultiSpot delivery modes for retinal and other ophthalmic laser treatments.

Companies that use Ellex

Customer profile

Segments4 records

Ideal customer profiles1 record

Ellex technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Ellex partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Ellex competitors and assessment

Company assessment

Direct peers

  • Lumenis: Lumenis is a direct competitor in ophthalmic lasers with YAG, SLT, and retina laser systems sold into similar ophthalmologist and hospital channels. Its product portfolio directly overlaps Ellex's Tango, Ultra Q, and Solo families.
  • Iridex: Iridex manufactures ophthalmic laser systems for glaucoma and retinal treatments, directly overlapping Ellex's SLT and retinal photocoagulation product lines. Both companies target retina and glaucoma specialists with comparable capital equipment.
  • Quantel Medical: Quantel Medical is a sister brand under Lumibird Medical, marketing adjacent ophthalmic laser and ultrasound products. It shares customer base, distribution, and parent-company support with Ellex, and competes for overlapping ophthalmic device budgets.
  • Optotek Medical: Optotek Medical is a sister brand under Lumibird Medical with overlapping ophthalmic laser and diagnostic offerings. It shares the same parent company, sales channels, and clinical customer base as Ellex, making it the closest internal peer.

Broad incumbents

  • Nidek: Nidek is a broad ophthalmic device incumbent offering YAG/SLT lasers, photocoagulators, and diagnostic platforms globally. It competes with Ellex across multiple laser modalities and benefits from a much larger portfolio and broader geographic footprint.
  • Carl Zeiss Meditec: Zeiss Meditec is a dominant ophthalmic surgical and diagnostic incumbent whose laser offerings (YAG, retina) directly overlap Ellex's product range. Its bundled capital equipment solutions and global scale make it a powerful competitor in shared accounts.
  • Alcon: Alcon is one of the largest global ophthalmic device companies, with laser, IOL, and phaco systems that compete with Ellex's offerings in cataract and glaucoma procedure rooms. Its scale and bundled procurement programs create competitive pressure on standalone laser specialists.
  • Bausch + Lomb: Bausch + Lomb operates across ophthalmic pharmaceuticals, IOLs, and surgical devices including laser platforms. It competes with Ellex for ophthalmologist capital expenditure and offers bundled cataract surgery suites that include laser technology.
  • Topcon Healthcare: Topcon Healthcare offers a broad ophthalmic portfolio spanning diagnostic imaging, refractive, and surgical laser systems. It serves the same ophthalmologist customer base as Ellex and competes in capital equipment purchasing decisions.

Emerging players

  • LightMed: LightMed is a smaller ophthalmic laser specialist with YAG and SLT platforms that directly compete with Ellex's Tango and Solo lines. It represents an emerging alternative for cost-conscious ophthalmology practices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Ellex social profiles

Digital presence

Ellex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ellex leadership team

Management profile

Number of profiles

Ellex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ellex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ellex

What does Ellex do?

Ellex designs, manufactures, and sells ophthalmic laser systems used by eye-care professionals to treat anterior segment and retinal conditions. Its portfolio includes YAG lasers (for capsulotomy and iridotomy), Selective Laser Trabeculoplasty (SLT) lasers for glaucoma, and 577nm/532nm retinal photocoagulators with SingleSpot, MultiSpot, and Subliminal treatment modes. Products are sold globally as part of the Lumibird Medical portfolio under the Ellex brand.

Is Ellex a public or private company?

Ellex is a private company. It is classified as corporate owned and is currently operating.

When was Ellex founded?

Ellex was founded in 1985. It employs 101 to 250 people.

Where is Ellex based?

Ellex is headquartered in Coalstoun Lakes, Australia, in the Oceania region.

Who are Ellex's main competitors?

Direct peers on record are Lumenis, Iridex, Quantel Medical and Optotek Medical. Broad incumbents are Nidek, Carl Zeiss Meditec, Alcon, Bausch + Lomb and Topcon Healthcare. LightMed is listed as an emerging player.

Does Ellex have an API?

No public API is recorded for Ellex.

What industry is Ellex in?

Ellex's product category is Ophthalmic Medical Devices. Its primary akta.pro industry code is HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics). Its NAICS code is 339115 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireWorldwide Ophthalmic Photocoagulator Industry to 2028 - Players Include Lumenis, Alcon and Quantel Medical Among OthersResearchAndMarkets.com published a global market research report on the ophthalmic photocoagulator market, projecting it to reach USD 213.2 million by 2028, growing at a CAGR of 4.7% from 2021 to 2028. The report identifies rising geriatric populations, increasing ophthalmic disorders, and technological advancements as key growth drivers, while COVID-19 is expected to negatively impact market growth due to delayed routine ophthalmic procedures. Quantel Medical acquired Ellex, including its laser technology solutions, as part of a strategic consolidation among market participants.GlobeNewswireERRATUM - LUMIBIRD: 2021 FIRST-QUARTER REVENUESLUMIBIRD reported consolidated revenues of €33.8 million for Q1 2021, up 54% year-on-year, driven by the integration of Ellex's laser and ultrasound activities. Pro-forma revenues were up 3.2% and 5.0% at constant exchange rates, with the Medical division growing 124% and Photonics up 9%.GlobeNewswireLumibird / h1 Earnings: Income From Ordinary Operations Growth in a Crisis ContextLumibird reported H1 2020 revenue of €45.8m, down 11.5%, with operating income of €2.9m, up 9.7%. The company finalized its Ellex acquisition, doubling its Medical division, and plans to present new strategic objectives before year-end.GlobeNewswireLumiBIRD: 2020 FIRST-HALF REVENUES (ERRATUM )Lumibird reported first-half 2020 revenues of €46.2m, down 10.6% year-over-year, with pro forma revenues of €65m including Ellex. The Medical division fell 10.5% to €15.8m, while Lidar grew 7.2% to €9.4m. The company expects to offset the sales decline through expense reductions.GlobeNewswireLUMIBIRD: 2020 FIRST-HALF REVENUESLumibird reported first-half 2020 consolidated revenues of €46.2m, down 10.6% year-on-year, with pro forma revenues of €65m including Ellex. The Medical division fell 10.5% to €15.8m, while Lidar grew 7.2% to €9.4m. The company expects to offset the sales decline through expense reductions.GlobeNewswireLumibird Finalizes Its Acquisition of Ellex’s Laser and Ultrasound ActivitiesLUMIBIRD finalized its acquisition of Ellex's laser and ultrasound activities on June 30, 2020, for AUD 100m. The deal doubled the size of its Medical division, which now represents over half of the group's revenues. The acquisition strengthens LUMIBIRD's position in ophthalmic laser and ultrasound technologies.GlobeNewswireLumibird: Go-Ahead From the Accc for the Acquisition of Ellex’s Laser and Ultrasound BusinessLumibird received ACCC clearance to acquire Ellex's laser and ultrasound business, with completion expected by June 30. Lumibird, a laser technology leader, has over 500 employees and €110 million in 2019 revenue.PR NewswireGlobal $3 Billion Retinal Surgery Device Market 2018-2024 - Ophthalmic Devices Sector Likely to Make Double Digit Expansion Driven by Baby Boomer Aging PopulationA market research report by Research and Markets projects that the global retinal surgery device market will exceed US$ 3 billion by 2024, driven by an aging baby boomer population and technological advancements in the ophthalmic devices sector. The report identifies vitrectomy machines and retinal lasers as the highest-revenue segments, while diseases such as cataracts, glaucoma, diabetic retinopathy, and AMD continue to drive demand. Key market players analyzed include Alcon Laboratories, Carl Zeiss, Topcon Corporation, Valeant Pharmaceuticals International, Iridex Corporation, Ellex Medical Lasers, Escalon Medical, and Second Sight Medical Products.PR NewswireOphthalmic Diagnostic Equipment Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025This is an industry market report analyzing the global ophthalmic diagnostic equipment market, covering key segments including optical coherence tomography (OCT), ophthalmoscope, fundus camera, and other diagnostic devices. The report identifies major market players including TOPCON CORPORATION, Carl Zeiss Vision International GmbH, Ellex, Quantel Medical Inc, NIDEK CO., LTD, HAAG-STREIT GROUP, Halma plc, Coburn Technologies Inc., and Kowa Company Ltd., and forecasts market performance across North America, Western Europe, Asia Pacific, and other regions through 2025.PR NewswireGlobal Ophthalmology Drugs and Devices Market 2015-2021 - Top Players are Alcon, Ellex Medical Lasers, Essilor International, Allergan, Bausch & Lomb, Carl Zeiss, J&J and HoyaThis is a market research report by Research and Markets providing analysis of the global ophthalmology drugs and devices market for 2015-2021, projecting a 7% compound annual growth rate during the forecast period. The report identifies key growth drivers including increasing prevalence of eye disorders such as glaucoma and cataract, an aging global population, new regulatory approvals, and advancement in minimally invasive surgical technologies. The competitive landscape section profiles numerous companies operating in this sector, including both pharmaceutical and medical device manufacturers.